Demystifying Cancer Immunotherapy for Lay Audiences

Kiara Ellis; Christopher A. Pennell

doi:10.3389/fimmu.2019.02488

Demystifying Cancer Immunotherapy for Lay Audiences

Kiara Ellis
, Christopher A. Pennell

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Immunotherapy is now mainstream. Advertisements are ubiquitous in print and visual media for immune based-therapies for various conditions and diseases. Smaller companies that develop novel immunotherapies are often quickly acquired by larger companies. More and more clinical trials are open for immune-based therapies, particularly for immune checkpoint blockades. As such, immunologists need to engage the public in conversations about the strengths and limitations of immunotherapy, and the necessity of research in propelling the field further. In this article, we discuss approaches we have taken to convey key concepts in immunology and cancer immunotherapy to non-scientists and health care professionals without expertise in immunology. Although the devil is always in the details, basic concepts in immunology and immunotherapy can be readily conveyed using stories and analogies, some of which we present here.

Original language	English (US)
Article number	2488
Journal	Frontiers in immunology
Volume	10
DOIs	https://doi.org/10.3389/fimmu.2019.02488
State	Published - Oct 18 2019

Bibliographical note

Funding Information:
We gratefully acknowledge the philanthropic support of the Minnesota Masonic Charities and MCC’s Cancer Center Support Grant from the NCI (P30-CA077598-21).

Funding Information:
We thank the other members of MCC's Office of Community Engagement and Education: Patricia Beckmann, Sylvette Lopez-Ruth, and Lisandrea Martinez. Funding. We gratefully acknowledge the philanthropic support of the Minnesota Masonic Charities and MCC's Cancer Center Support Grant from the NCI (P30-CA077598-21).

Publisher Copyright:
© Copyright © 2019 Ellis and Pennell.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being
SDG 16 Peace, Justice and Strong Institutions

Keywords

cancer
community
engagement
immunotherapy
outreach

Publisher link

10.3389/fimmu.2019.02488

Find It

Find It at U of M Libraries

Cite this

@article{91532cf394b24fc69395ecc06cde0679,

title = "Demystifying Cancer Immunotherapy for Lay Audiences",

abstract = "Immunotherapy is now mainstream. Advertisements are ubiquitous in print and visual media for immune based-therapies for various conditions and diseases. Smaller companies that develop novel immunotherapies are often quickly acquired by larger companies. More and more clinical trials are open for immune-based therapies, particularly for immune checkpoint blockades. As such, immunologists need to engage the public in conversations about the strengths and limitations of immunotherapy, and the necessity of research in propelling the field further. In this article, we discuss approaches we have taken to convey key concepts in immunology and cancer immunotherapy to non-scientists and health care professionals without expertise in immunology. Although the devil is always in the details, basic concepts in immunology and immunotherapy can be readily conveyed using stories and analogies, some of which we present here.",

keywords = "cancer, community, engagement, immunotherapy, outreach",

author = "Kiara Ellis and Pennell, \{Christopher A.\}",

note = "Funding Information: We gratefully acknowledge the philanthropic support of the Minnesota Masonic Charities and MCC{\textquoteright}s Cancer Center Support Grant from the NCI (P30-CA077598-21). Funding Information: We thank the other members of MCC's Office of Community Engagement and Education: Patricia Beckmann, Sylvette Lopez-Ruth, and Lisandrea Martinez. Funding. We gratefully acknowledge the philanthropic support of the Minnesota Masonic Charities and MCC's Cancer Center Support Grant from the NCI (P30-CA077598-21). Publisher Copyright: {\textcopyright} Copyright {\textcopyright} 2019 Ellis and Pennell.",

year = "2019",

month = oct,

day = "18",

doi = "10.3389/fimmu.2019.02488",

language = "English (US)",

volume = "10",

journal = "Frontiers in immunology",

issn = "1664-3224",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Demystifying Cancer Immunotherapy for Lay Audiences

AU - Ellis, Kiara

AU - Pennell, Christopher A.

N1 - Funding Information: We gratefully acknowledge the philanthropic support of the Minnesota Masonic Charities and MCC’s Cancer Center Support Grant from the NCI (P30-CA077598-21). Funding Information: We thank the other members of MCC's Office of Community Engagement and Education: Patricia Beckmann, Sylvette Lopez-Ruth, and Lisandrea Martinez. Funding. We gratefully acknowledge the philanthropic support of the Minnesota Masonic Charities and MCC's Cancer Center Support Grant from the NCI (P30-CA077598-21). Publisher Copyright: © Copyright © 2019 Ellis and Pennell.

PY - 2019/10/18

Y1 - 2019/10/18

N2 - Immunotherapy is now mainstream. Advertisements are ubiquitous in print and visual media for immune based-therapies for various conditions and diseases. Smaller companies that develop novel immunotherapies are often quickly acquired by larger companies. More and more clinical trials are open for immune-based therapies, particularly for immune checkpoint blockades. As such, immunologists need to engage the public in conversations about the strengths and limitations of immunotherapy, and the necessity of research in propelling the field further. In this article, we discuss approaches we have taken to convey key concepts in immunology and cancer immunotherapy to non-scientists and health care professionals without expertise in immunology. Although the devil is always in the details, basic concepts in immunology and immunotherapy can be readily conveyed using stories and analogies, some of which we present here.

AB - Immunotherapy is now mainstream. Advertisements are ubiquitous in print and visual media for immune based-therapies for various conditions and diseases. Smaller companies that develop novel immunotherapies are often quickly acquired by larger companies. More and more clinical trials are open for immune-based therapies, particularly for immune checkpoint blockades. As such, immunologists need to engage the public in conversations about the strengths and limitations of immunotherapy, and the necessity of research in propelling the field further. In this article, we discuss approaches we have taken to convey key concepts in immunology and cancer immunotherapy to non-scientists and health care professionals without expertise in immunology. Although the devil is always in the details, basic concepts in immunology and immunotherapy can be readily conveyed using stories and analogies, some of which we present here.

KW - cancer

KW - community

KW - engagement

KW - immunotherapy

KW - outreach

UR - https://www.scopus.com/pages/publications/85074428860

UR - https://www.scopus.com/pages/publications/85074428860#tab=citedBy

U2 - 10.3389/fimmu.2019.02488

DO - 10.3389/fimmu.2019.02488

M3 - Article

C2 - 31681338

AN - SCOPUS:85074428860

SN - 1664-3224

VL - 10

JO - Frontiers in immunology

JF - Frontiers in immunology

M1 - 2488

ER -

Demystifying Cancer Immunotherapy for Lay Audiences

Abstract

Bibliographical note

UN SDGs

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this